About Antifungal Drugs
Antifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption.
Technavio’s analysts forecast the global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Antifungal Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Pfizer
• Merck
• Astellas Pharma
• Novartis
• Johnson & Johnson
Other prominent vendors
• Allergan
• Almirall
• Amgen
• Aqua Pharmaceuticals
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Dermira
• Elorac
• F. Hoffmann-La Roche
• Galderma
• Genentech
• GlaxoSmithKline
• Hexima
• Hisamitsu Pharmaceutical
• Incyte
• Mayne Pharma
• MediQuest Therapeutics
• Meiji Seika Pharma
• Merz Pharmaceuticals
• Moberg Pharma
• Mylan Pharmaceuticals
• NanoBio
• NovaBiotics
• Novan
• Nuvo Research
• Polichem
• Promius Pharma
• Sanofi
• Seren Pharmaceuticals
• Sun Pharma
• Taro
• Teva Pharmaceutical
• Theravance Biopharma
• Topica Pharmaceuticals
• Viamet Pharmaceuticals
Market driver
• Rising popularity of OTC antifungal drugs for dermal infections
• For a full, detailed list, view our report
Market challenge
• Antifungal drug resistance
• For a full, detailed list, view our report
Market trend
• Increased funding for antifungal research
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by ROA
• Global oral antifungal drugs market
• Global parenteral antifungal drugs market
• Global topical antifungal drugs market
PART 07: Market segmentation by type
• Global prescription antifungal drugs market
• Global OTC antifungal drugs market
PART 08: Market segmentation by chemical class
PART 09: Geographical segmentation
• Antifungal drugs market in Americas
• Antifungal drugs market in the US
• Antifungal drugs market in EMEA
• Antifungal drugs market in Europe
• Antifungal drugs market in APAC
• Antifungal drugs market in Japan
PART 10: Market drivers
• QIDP and other special regulatory designations
• Increase in prevalence of infections and environmental changes
• Rising popularity of OTC antifungal drugs for dermal infections
PART 11: Impact of drivers
PART 12: Market challenges
• Antifungal drug resistance
• Increased availability of generics and alternative therapies
• Poor patient adherence
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Increased funding for antifungal research
• Increased focus on combination therapies
• Incorporation of novel technology for product development
• Strategic alliances and M&A
PART 15: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 16: Key vendor analysis
• Astellas Pharma
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Market snapshot of global antifungal drugs market
Exhibit 02: Overview of global antifungal drugs market 2016-2021
Exhibit 03: Global antifungal drugs market snapshot: Developed and emerging markets 2016-2021
Exhibit 04: Global antifungal drugs market 2016-2021 ($ billions)
Exhibit 05: Opportunity analysis in global antifungal drugs market
Exhibit 06: Impact of factors affecting the market 2016 and 2021
Exhibit 07: Impact of key customer segments on global antifungal drugs market 2016
Exhibit 08: Five forces analysis
Exhibit 09: Share of global antifungal drugs by ROA 2016 and 2021
Exhibit 10: Market overview of global oral antifungal drugs market
Exhibit 11: Market overview of global parenteral antifungal drugs market
Exhibit 12: Market overview of global topical antifungal drugs market
Exhibit 13: Global antifungal drugs market segmentation by type 2016
Exhibit 14: Market overview of global prescription antifungal drugs market
Exhibit 15: Market overview of global OTC antifungal drugs market
Exhibit 16: Types of anti-fungal drugs by chemical class
Exhibit 17: Global antifungal drugs market: Segmentation by geography (2016-2021)
Exhibit 18: Global antifungal drugs market segmentation by region: Market growth lifecycle analysis 2016
Exhibit 19: Overview of antifungal drugs market in Americas
Exhibit 20: Antifungal drugs market in Americas 2016-2021 ($ billions)
Exhibit 21: Opportunity analysis in antifungal drugs market in Americas
Exhibit 22: Overview of antifungal drugs market in the US
Exhibit 23: Overview of antifungal drugs market in EMEA
Exhibit 24: Antifungal drugs market in EMEA 2016-2021 ($ billions)
Exhibit 25: Opportunity analysis in antifungal drugs market in EMEA
Exhibit 26: Overview of antifungal drugs market in Europe
Exhibit 27: Overview of antifungal drugs market in APAC
Exhibit 28: Antifungal drugs market in APAC 2016-2021 ($ billions)
Exhibit 29: Opportunity analysis in antifungal drugs market in APAC
Exhibit 30: Overview of antifungal drugs market in Japan
Exhibit 31: Impact of drivers and challenges on global antifungal drugs market
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Impact of trends in global antifungal drugs market
Exhibit 35: Competitive structure analysis of global antifungal drugs market 2016
Exhibit 36: Competitive analysis of global antifungal drugs market
Exhibit 37: Market penetration of various antifungal drug makers worldwide 2016
Exhibit 38: Astellas Pharma: Key highlights
Exhibit 39: Astellas Pharma: Strength assessment
Exhibit 40: Astellas Pharma: Strategy assessment
Exhibit 41: Astellas Pharma: Opportunity assessment
Exhibit 42: Johnson & Johnson: Key highlights
Exhibit 43: Johnson & Johnson: Strength assessment
Exhibit 44: Johnson & Johnson: Strategy assessment
Exhibit 45: Johnson & Johnson: Opportunity assessment
Exhibit 46: Merck: Key highlights
Exhibit 47: Merck: Strength assessment
Exhibit 48: Merck: Strategy assessment
Exhibit 49: Merck: Opportunity assessment
Exhibit 50: Novartis: Key highlights
Exhibit 51: Novartis: Strength assessment
Exhibit 52: Novartis: Strategy assessment
Exhibit 53: Novartis: Opportunity assessment
Exhibit 54: Pfizer: Key highlights
Exhibit 55: Pfizer: Strength assessment
Exhibit 56: Pfizer: Strategy assessment
Exhibit 57: Pfizer: Opportunity assessment
